Skip to main content
Welcome
Register
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegrates
Login Required
Schedule
Daily Schedule
Wednesday, November 13, 2024
Thursday, November 14, 2024
Friday, November 15, 2024
Saturday, November 16, 2024
Primary Author
Title
Posters
Primary Author
Number
Title
Category
Poster Galley
Login Required
Poster Award Winners
Sponsors
Sponor Events
Visit Our Sponsors
Thank You Sponsors
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Welcome Reception
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Printable Material
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotel
Booking Link
Hotel FAQ's
Statement of Conduct
FAQ
Toggle navigation
Login
Search
Home
Welcome
Register
Survey
Login Required
Download the App
My Experience
Login Required
People
Oral Presenters
Poster Presenters
Delegrates
Login Required
Schedule
Daily Schedule
Wednesday, November 13, 2024
Thursday, November 14, 2024
Friday, November 15, 2024
Saturday, November 16, 2024
Primary Author
Title
Posters
Primary Author
Number
Title
Category
Poster Galley
Login Required
Poster Award Winners
Sponsors
Sponor Events
Visit Our Sponsors
Thank You Sponsors
Sunrise Mentorship Program
CTOS Networking Events
Networking Events
Welcome Reception
Gala
Ancillary Events
Patient Advocacy
About SPAGN
SPAGN Events
Printable Material
Schedule at a Glance
Oral Presentations
Login Required
Poster Presentations
Login Required
Hotel
Booking Link
Hotel FAQ's
Statement of Conduct
FAQ
Schedule at a Glance
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Tweet
Print
Christine A. Pratilas, MD
Associate Professor of Oncology & Pediatrics
Johns Hopkins University School of Medicine
Poster(s):
(P 152) NOVEL PAX3::MAML3 FUSION IDENTIFIED IN ALVEOLAR RHABDOMYOSARCOMA: USING DNA METHYLATION TO EXPANDE THE GENETIC SPECTRUM OF "FUSION POSITIVE" CASES
(P 187) BRIDGING THE GAP: UNDERSTANDING THE CURRENT TREATMENT RESPONSES TO ENHANCE THE STANDARD OF CARE AND OUTCOMES FOR MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
(P 309) PHASE II TRIAL OF GEMCITABINE AND NAB-PACLITAXEL IN PATIENTS WITH RECURRENT SOFT TISSUE SARCOMA: A REPORT FROM THE NATIONAL PEDIATRIC CANCER FOUNDATION
Back to Top